Metabolic engineering of Escherichia coli BL21 (DE3) for de novo production of l-DOPA from d-glucose

BACKGROUND: Production of l-tyrosine is gaining grounds as the market size of 3,4-dihydroxyphenyl-l-alanine (l-DOPA) is expected to increase due to increasing cases of Parkinson’s disease a neurodegenerative disease. Attempts to overproduce l-tyrosine for conversion to l-DOPA has stemmed on the over...

Descripción completa

Detalles Bibliográficos
Autores principales: Fordjour, Eric, Adipah, Frederick Komla, Zhou, Shenghu, Du, Guocheng, Zhou, Jingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482505/
https://www.ncbi.nlm.nih.gov/pubmed/31023316
http://dx.doi.org/10.1186/s12934-019-1122-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482505/
https://www.ncbi.nlm.nih.gov/pubmed/31023316
http://dx.doi.org/10.1186/s12934-019-1122-0

Ejemplares similares